Flemingvoldt PLLC

New Jersey

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Cases21

Challenger50%

Patent Owner50%

NPE50%

Practice Areas

BiotechChemical

Top Attorneys

Patrick J. CoyneNeal S. CohenPeter Kinsella

Elite Ratings

DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Experience

Grade

Trend

DCT

PTAB

CAFC

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered	Case	Description
08/11/23	IN RE SUGAMMADEX 2:20-CV-02576 ( D. NJ )	USCA Case Number 23-2254 for 424 Notice of Appeal (Federal Circuit), (Document Restricted - Court Only) (adc, ) (Entered: 08/11/2023)
08/11/23	IN RE SUGAMMADEX 2:20-CV-02576 ( D. NJ )	USCA Case Number 23-2254 for 424 Notice of Appeal (Federal Circuit), (Document Restricted - Court Only) (adc, ) (Entered: 08/11/2023)
08/01/22	Sebela Intl Ltd v. Prinston Pharmaceutical Inc 2:17-CV-04964 ( D. NJ )	JOINT STIPULATION & ORDER OF DISMISSAL. Signed by Judge Claire C. Cecchi on 7/31/2022. (jl, ) (Entered: 08/01/2022)
11/22/21	Celgene Corp v. Hetero Labs Ltd 2:17-CV-03387 ( D. NJ )	Pursuant to Local Rule 79.4, notice is hereby given of the Appellate ruling filed on: 11/22/2021. In the event that the mandate or judgment provides for costs or directs a disposition other than an affirmance, the prevailing party shall prepare and submit an order implementing the mandate or judgment. (wh)
	Celgene Corp v. Hetero Labs Ltd 2:17-CV-03387 ( D. NJ )	MANDATE of Federal Circuit as to [952] Notice of Appeal (Federal Circuit), filed by CELGENE CORPORATION (Finance notified). ORDER granting motion to dismiss appeal pursuant to FRAP 42(b) [13] filed by Appellant Celgene Corporation. Issuing mandate. (wh)
11/22/21	Celgene Corp v. Hetero Labs Ltd 2:17-CV-03387 ( D. NJ )	MANDATE of Federal Circuit as to [952] Notice of Appeal (Federal Circuit), filed by CELGENE CORPORATION (Finance notified). ORDER granting motion to dismiss appeal pursuant to FRAP 42(b) [13] filed by Appellant Celgene Corporation; issuing mandate. (wh) (Entered: 11/22/2021)
11/22/21	Celgene Corp v. Hetero Labs Ltd 2:17-CV-03387 ( D. NJ )	Pursuant to Local Rule 79.4, notice is hereby given of the Appellate ruling filed on 11/22/2021. In the event that the mandate or judgment provides for costs or directs a disposition other than an affirmance, the prevailing party shall prepare and submit an order implementing the mandate or judgment. (wh) (Entered: 11/22/2021)
	IN RE SEBELA Patent LITIGATION 2:14-CV-06414 ( D. NJ )	BRIEF in Opposition filed by SEBELA INTERNATIONAL LIMITED re [365] MOTION for Taxation of Costs (Attachments: # [1] Declaration of Justin T. Quinn, # [2] Exhibit A, # [3] Exhibit B, # [4] Exhibit C)(QUINN, JUSTIN)
	Celgene Corp v. Breckenridge Pharmaceutical Inc 2:19-CV-05804 ( D. NJ )	REDACTION to [98] Letter, [99] Exhibit (to Document) by Melissa E. Flax. (FLAX, MELISSA)
03/17/20	Celgene Corp v. Breckenridge Pharmaceutical Inc 2:20-CV-02597 ( D. NJ )	SUMMONS ISSUED as to BRECKENRIDGE PHARMACEUTICAL, INC., NATCO PHARMA LIMITED. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (ld, ) (Entered: 03/17/2020)